Chao Xing Selected Research

Neoplasm Metastasis (Metastasis)

12/2021	Chronic IL-1 Exposed AR+ PCa Cell Lines Show Conserved Loss of IL-1 Sensitivity and Evolve Both Conserved and Unique Differential Gene Expression Profiles.
10/2021	"Don't eat me/eat me"-combined apoptotic body analogues for efficient targeted therapy of triple-negative breast cancer.
8/2021	IncRNA LUCAT1 acts as a Potential Biomarker and Demonstrates Malignant Biological Behaviors in Gastric Cancer.
1/2021	Computed Tomography‒Guided Microwave Ablation Combined with Osteoplasty for the Treatment of Bone Metastases: A Multicenter Clinical Study.
1/2020	HIF2-Induced Long Noncoding RNA RAB11B-AS1 Promotes Hypoxia-Mediated Angiogenesis and Breast Cancer Metastasis.
12/2019	Combination of Microwave Ablation and Percutaneous Osteoplasty for Treatment of Painful Extraspinal Bone Metastasis.
1/2018	Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells.
12/2015	Clinicopathologic features and treatment of breast metastasis from nasopharyngeal carcinoma: A report of two cases and literature review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chao Xing Research Topics

Disease

32	Neoplasms (Cancer) 01/2022 - 01/2014
8	Neoplasm Metastasis (Metastasis) 12/2021 - 12/2015
6	Inflammation (Inflammations) 12/2021 - 01/2019
5	Breast Neoplasms (Breast Cancer) 01/2021 - 05/2016
5	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2017
4	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2009
4	Fuchs' Endothelial Dystrophy 01/2020 - 02/2015
4	Fibrosis (Cirrhosis) 01/2019 - 09/2011
4	Non-alcoholic Fatty Liver Disease 01/2019 - 11/2012
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2010 - 05/2007
3	Carcinogenesis 01/2022 - 01/2017
3	Hypoxia (Hypoxemia) 01/2021 - 01/2020
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 11/2017
3	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2021 - 01/2016
3	Infections 01/2020 - 10/2015
3	Disease Progression 01/2020 - 01/2014
3	Myocardial Infarction 01/2019 - 01/2011
3	Hypertension (High Blood Pressure) 01/2018 - 04/2006
3	Hypertriglyceridemia 01/2017 - 07/2016
3	Liver Diseases (Liver Disease) 12/2015 - 05/2010
2	Esophageal Squamous Cell Carcinoma 01/2022 - 01/2021
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2015
2	Starvation 01/2022 - 01/2020
2	Myocarditis (Carditis) 12/2021 - 09/2007
2	Fatty Liver 11/2021 - 02/2015
2	Triple Negative Breast Neoplasms 10/2021 - 01/2021
2	Stomach Neoplasms (Stomach Cancer) 08/2021 - 10/2018
2	Atrophy 01/2021 - 07/2016
2	Glaucoma 01/2021 - 01/2018
2	Cysts 01/2021 - 01/2016
2	Glioma (Gliomas) 10/2020 - 01/2020
2	Progeria (Hutchinson Gilford Syndrome) 10/2020 - 09/2017
2	Lipodystrophy 09/2017 - 12/2010
2	Hyperglycemia 07/2016 - 02/2015
2	Atherosclerosis 02/2015 - 03/2010
2	Idiopathic Pulmonary Fibrosis 09/2011 - 05/2010
1	Lymphatic Metastasis 01/2022
1	Alcoholic Fatty Liver 01/2022
1	Myopia 01/2022
1	Vascular Calcification 01/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 12/2021
1	Pathologic Processes 12/2021
1	Bites and Stings (Sting) 11/2021
1	Genetic Risk Score 09/2021
1	Hypoproteinemia 05/2021

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2009
10	Messenger RNA (mRNA)IBA 01/2022 - 01/2018
8	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2008
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
7	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2016
6	Small Interfering RNA (siRNA)IBA 01/2022 - 03/2018
6	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2016
6	Biological ProductsIBA 12/2021 - 12/2019
5	Transcription Factors (Transcription Factor)IBA 01/2022 - 05/2016
5	Long Noncoding RNAIBA 12/2021 - 01/2018
5	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2020 - 05/2007
4	Pharmaceutical PreparationsIBA 01/2022 - 02/2019
4	Interleukin-1 (Interleukin 1)IBA 12/2021 - 01/2018
4	ChromatinIBA 01/2021 - 01/2017
4	Retinaldehyde (Retinal)IBA 01/2021 - 04/2006
4	RNA Polymerase II (RNA Polymerase B)IBA 01/2020 - 01/2018
3	LipidsIBA 01/2022 - 02/2015
3	CytokinesIBA 12/2021 - 01/2018
3	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 03/2010
3	Triglycerides (Triacylglycerol)IBA 11/2016 - 02/2015
2	Therapeutic UsesIBA 01/2022 - 02/2019
2	ferruginolIBA 01/2021 - 11/2017
2	Particulate MatterIBA 01/2021 - 01/2021
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 04/2014
2	Lamin Type A (Lamin A)IBA 10/2020 - 09/2017
2	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 01/2017
2	AndrogensIBA 01/2020 - 01/2017
2	Fish OilsIBA 11/2016 - 07/2016
2	Alanine Transaminase (SGPT)IBA 03/2016 - 02/2012
1	Hydroxyl RadicalIBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	Sodium-Phosphate Cotransporter Proteins (Sodium-Phosphate Cotransporter)IBA 01/2022
1	Antisense OligonucleotidesIBA 01/2022
1	Alkylating AgentsIBA 01/2022
1	Phosphates (Orthophosphate)IBA 01/2022
1	PolyaminesIBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 12/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021
1	PNU-282987IBA 12/2021
1	extracellular matrix receptorIBA 12/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 11/2021
1	Insulin ReceptorIBA 11/2021
1	SaporinsIBA 10/2021
1	oxidized low density lipoproteinIBA 09/2021

Therapy/Procedure

12	Therapeutics 01/2022 - 11/2016
3	Radiotherapy 01/2018 - 01/2014
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2020
2	Brachytherapy 01/2022 - 01/2021
2	Immunotherapy 01/2020 - 10/2017
1	RNAi Therapeutics 01/2022
1	Salvage Therapy 01/2022
1	Vagotomy 12/2021
1	Castration 12/2021